Get the Stockscreener App
0.97
2.11%
0.02
After Hours:
.97
Why is Nextcure Inc (NXTC) Stock down?
We've noticed a 10.82% decline in Nextcure Inc (NXTC) stock during the 2024-12-17 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
14 Dec, 2023:
Shares of Nextcure Inc (NXTC) dropped by 19.31% from $1.45 to $1.17 in the trading on Thursday, December 14, 2023. The reason why NXTC down today is due to the company on its clinical pipeline. Nextcure Inc disclosed that it was currently conducting an ongoing Phase 1b trial of NC410 in combination with pembrolizumab. Additionally, the company stated that it was actively seeking strategic partners to accelerate the development of its pipeline. It's possible that investors reacted negatively to this update, which may have contributed to the sharp decrease in NXTC's share price on December 14, 2023.
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):